Disc Medicine (IRON) Accumulated Depreciation (2020 - 2024)

Disc Medicine (IRON) has reported Accumulated Depreciation for 5 consecutive years, with $401000.0 the latest figure, recorded in Q4 2024.

• In Q4 2024, Accumulated Depreciation rose 63.67% year-over-year to $401000.0; the TTM figure through Dec 2024 stood at $401000.0 (up 63.67% YoY), while the FY2024 annual figure was $401000.0, up 63.67% from the prior year.
• Accumulated Depreciation climbed to $401000.0 in Q4 2024 per IRON's latest filing, from $392000.0 in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $661000.0 in Q4 2020 and bottomed at $56000.0 in Q4 2021.
• Historically, Accumulated Depreciation has averaged $285181.8 across 5 years, with a median of $245000.0 in 2023.
• Annual changes were most pronounced in 2021 — Accumulated Depreciation slumped 91.53% — and 2022, when it jumped 158.93%.
• Disc Medicine's Accumulated Depreciation stood at $661000.0 in 2020, then sank by 91.53% to $56000.0 in 2021, then surged by 158.93% to $145000.0 in 2022, then surged by 68.97% to $245000.0 in 2023, then soared by 63.67% to $401000.0 in 2024.
• Business Quant data shows IRON's Accumulated Depreciation at $401000.0 in Q4 2024, $392000.0 in Q3 2024, and $381000.0 in Q2 2024.